##  [SAHPRA Drug Registration Process: Step-by-Step Guide for Pharmaceutical Companies](/blog/sahpra-drug-registration-process-step-by-step-guide-for-pharmaceutical-companies) 

    September 12, 2025 

  ![SAHPRA Drug Registration Process: Step-by-Step Guide for Pharmaceutical Companies]()

2 min read 

- [Medicinal Products](/blog-main-categories/medicinal-products)
- [Regulatory Affairs](/blog-main-categories/regulatory-affairs)





 

The South African Health Products Regulatory Authority (SAHPRA) is responsible for ensuring the safety, efficacy, and quality of medicines and related substances. For pharmaceutical companies planning to enter the South African market, navigating the SAHPRA drug registration process is a critical step. Below is a structured overview of the end-to-end process.

### 1) Classify the application & select a review pathway

Decide NCE, biological, generic, line extension, or duplicate. Choose **Full**, **Reliance (abridged)**, or **Priority** review based on data and prior approvals from recognized authorities.

### 2) Appoint the local authorization holder (HCR) & confirm licences

Nominate a South African legal entity as the **Holder of the Certificate of Registration**. Ensure relevant manufacturing/wholesale licences and GMP evidence are in place for all sites.

### 3) Map your data strategy

For NCEs/biologicals: align nonclinical/clinical data to CTD expectations. For generics: define BE strategy (reference product, design, endpoints) and stability program (long-term/accelerated) per ICH-aligned practice referenced by SAHPRA guidance.

### 4) Choose format: eCTD with ZA Module 1

SAHPRA **eCTD** with **ZA-specific Module 1** and regional sections 2.3R/3.2R. Build a complete CTD:

**Module 1 (ZA):** forms, proof of fee, HCR details, labeling (PI/PIL), risk management, PV contacts.

**Module 2:** QOS and overviews.

**Module 3–5:** CMC, nonclinical/clinical or BE.

### 5) Authoring & publishing

Apply ZA granularity, naming, and lifecycle conventions; prepare a clean sequence with correct submission type and application metadata. Use the latest **General/Module 1 guidance** to avoid administrative screen-outs.

### 6) Validate technically

Run the **ZA eCTD Validation Criteria** in your validator and fix all critical/major errors. For variations and follow-up sequences, check SAHPRA’s **Validation Template** to mirror what the regulator will verify on receipt.

### 7) Pay fees & submit electronically

Pay the applicable application fee; include the proof in Module 1. Submit via SAHPRA’s eSubmission channel following ZA eCTD specifications (sequence structure, checksums, lifecycle).

### 8) Administrative screening

SAHPRA verifies format, completeness, correct forms/fees, labeling, and Module presence. Deficiencies trigger screening queries; resolve via a new sequence referencing the question log.

### 9) Scientific assessment

**Full review:** complete CMC/nonclinical/clinical assessment.

- provide proof of reference authority approval and alignment (e.g., unredacted reports where available); SAHPRA focuses on local-context elements.

### 10) Queries & responses (clock-stops)

Expect quality/clinical/BE/labeling questions. Respond within timelines; submit only changed/added docs with a response summary, following lifecycle rules.

### 11) Approval & certification

On approval, SAHPRA issues the **Certificate of Registration** with finalized PI/PIL and scheduling. Market only the registered particulars.

### 12) Post-registration compliance

- Pay **annual retention fees** to keep the registration/licence active (due by the last working day of June for 2025).
- File post-approval changes per SAHPRA’s variation processes.
- Maintain safety reporting and risk management.

**Pro tips to avoid delays**

Use **Reliance** when eligible to shorten timelines.

Front-load **stability/BE** plans and ensure labeling fully aligns with the clinical/BE evidence.

- every sequence; most rejections happen at technical/admin stages.

**Need hands-on help?**

Freyr supports **end-to-end SAHPRA submissions**—gap assessment, ZA Module 1 authoring, eCTD publishing/validation, reliance packaging, and lifecycle management. [**Partner with Freyr**](javascript:void(0)) **to fast-track compliant SAHPRA approval. Let’s talk.**